Search results for "Coronavirus"
Boosters, convalescent plasma, long-term effects, and other COVID-19 news
Government officials announced that they plan to offer booster shots for the mRNA COVID-19 vaccines. Convalescent plasma didn't improve outcomes for high-risk outpatients in a trial, and two studies reported long-term effects of hospitalization for COVID-19.
https://immattersacp.org/weekly/archives/2021/08/24/1.htm
24 Aug 2021
Guidance on using rapid tests, managing COPD, and screening for cardiac problems in COVID-19
The FDA warned about false positives with rapid tests, guidance addressed care for chronic obstructive pulmonary disease (COPD) during the pandemic, and experts advised on ethics of emergency use authorizations, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2020/11/10/1.htm
10 Nov 2020
COVID-19 news on monoclonal antibodies, psychiatric drug and complications
A monoclonal antibody received emergency use authorization, but experts described implementation challenges with this therapeutic class. New research found potential benefit from a psychiatric drug in COVID-19 outpatients and associations of COVID-19 with psychiatric disorders.
https://immattersacp.org/weekly/archives/2020/11/17/1.htm
17 Nov 2020
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
ACP, other groups address shortages of PPE, medications, tests during COVID-19 pandemic
The College praised the recently passed CARES Act for providing funding to increase the supply of personal protective equipment (PPE) but stressed that all possible means must be used to ensure sufficient PPE immediately for every physician, nurse, and health worker on the front lines.
https://immattersacp.org/weekly/archives/2020/03/31/1.htm
31 Mar 2020
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021
New data on delta variant of COVID-19 and vaccines
Recent research found that the risk of myocarditis and both arterial and venous clots is higher with COVID-19 infection than with vaccine administration. Other studies show that the COVID-19 delta variant has been associated with reduced mRNA vaccine effectiveness (from 91% to 66%) and an overall increased severity of illness.
https://immattersacp.org/weekly/archives/2021/08/31/1.htm
31 Aug 2021
COVID-19 studies look at transmission, cardiac effects, and lung ultrasound as triage
A review found most transmission to be respiratory, while a study suggested protection from eyeglasses. Data from athletes provided insight into cardiac effects, and lung ultrasound may be useful for triage. Philip A. Masters, MD, FACP, looked at how the pandemic has altered medicine.
https://immattersacp.org/weekly/archives/2020/09/22/1.htm
22 Sep 2020